We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies. Close

Claim news

Liability Risk and Insurance

Claim news

Johnson & Johnson in US$297 million settlement with Texas over opioid-related claims

Johnson & Johnson and its US-based Janssen Pharmaceutical Companies have announced a settlement agreement with the State of Texas and its participating subdivisions resolving their opioid-related claims against the company. Johnson & Johnson said that with this agreement, the company is removed from the pending Texas state and subdivision litigation, including two bellwether trials scheduled for early 2022.

The rest of this document is only available to i-law.com online subscribers.

If you are already a subscriber, please enter your details below to log in.

Enter your email address to log in as a user on your corporate account.
Remember me on this computer

Not yet an i-law subscriber?


Request a trial Find out more